Purple Biotech Insider Deals: CEO’s Deep‑Discount Options Stir Investor Alarm as AI‑Driven Antibody Push Looms
Insider activity at Purple Biotech shows Lankry Shai’s huge discounted stock options and RSUs, highlighting potential dilution, growth incentives, and AI‑driven antibody strategy.
3 minutes to read